无忧视频

Pioneering the next generation of mental health treatments
We are on a mission to develop effective, rapid-acting and accessible medicines for people living with mental health conditions
About Us
Self Reflected by Greg Dunn
Reducing
the unmet
need in
mental
health
Nearly 1 billion people suffer from mental disorders around the world.
The global economic cost of mental health disorders is expected to reach $6 trillion by 2030.
Most people living with a mental disorder do not have access to effective care.

We want to be a part of the solution.聽


Leveraging
the potential of
next-generation
compounds

Studies have shown that our investigational psychedelic-based compounds

can be administered in a short clinic visit
are well-tolerated
can deliver rapid, robust, and lasting treatment effects
More about
Our Pipeline
Therapeutic Focus
Clinical Trials
Supporting
patients
and
trial
participants

We are proud to support initiatives in-house and across the mental health landscape to accelerate research into novel mental health treatments and enhance the patient experience.

More about
Patients